Table 1.
Study sample by diagnostic groups with lifetime prevalence figures of autoimmune diseases covering the time before, during, and after the treatment for an eating disorder.
Table 2.
Period prevalences and results from conditional logistic regression models of autoimmune diseases from the start of the study period until the beginning of the treatment of an eating disorder.
Table 3.
Incidence of new onset autoimmune diseases after the start of the treatment for an eating disorder until the end of the study period.
Table 4.
Lifetime prevalences of autoimmune diseases, i.e. status at the end of the study period covering the time before, during and after the treatment for an eating disorder in patients with eating disorders compared with their control individuals.
Table 5.
Autoimmune disease status per each individual autoimmune disease included in the study at the end of the study period (covering the time before, during and after the treatment) for a composite of all patients with eating disorder compared with their control individuals.